As a pediatric interventional radiologist, I have a special interest in musculoskeletal lesion biopsies. I also pursue treatment systems improvement, especially for the prevention of injuries that occur from intravenous (IV) therapy placement. I co-led a hospital-level initiative to reduce injuries from peripheral IV therapy. The system we developed at Cincinnati Children’s has now been widely adopted nationally and internationally.
I wanted to be a physician from an early age, and I trained to be a pediatric interventional radiologist in Australia. I am good with visual, 3D and hand-eye coordination, and I use those skills to help sick children and their concerned families. I teach and practice the principle, "Do what you would do for your own children and family."
I practice full-time pediatric interventional radiology, which involves using medical imaging and guidance equipment to perform minimally invasive, surgery-equivalent procedures for children. These procedures include angiography, biopsies and drainage tube placement. In some cases, I do percutaneous (through the skin) treatments such as radiofrequency (heat) ablation of benign bone conditions, which replace more invasive procedures.
The recognitions I’ve received include:
I was also honored in 2012, when the Department of Radiology at Cincinnati Children's established an endowed Chair of Radiology Informatics in my name.
In my free time, I enjoy walking, reading, playing the piano and personal aviation.
MBBS: University of Melbourne, Melbourne, Victoria, Australia, 1976.
Residency: Royal Children's Hospital, Melbourne, Victoria, Australia, 1978-1979.
Fellowship: Pediatric Radiology, University of Rochester - Strong Memorial Hospital, Rochester, NY, 1985-1986.
Certification: US Radiology Board Certified, 1987; US Board of Radiology, Certificate of Added Qualifications - Pediatric Radiology, 2016 - present.
Pediatric radiology; pediatric interventional radiology; radiology informatics
Radiology, Interventional Radiology
Genome-Driven Therapy for Chemotherapy-Resistant Metastatic CDK6-Amplified Osteosarcoma. JCO Precision Oncology. 2020; 4:498-504.